Chilean Lawmakers Back Sofosbuvir Compulsory Licensing
Executive Summary
Chile’s lower house of congress has backed a resolution calling for the government to set the scene for the compulsory licensing of hepatitis C drugs.
You may also be interested in...
Sofosbuvir Compulsory License Nears In Chile
Generic competition is nearing for hepatitis C medicines formulated with Gilead’s sofosbuvir in Chile, following moves by the health ministry to allow compulsory licensing.
Sofosbuvir Compulsory License Nears In Chile
Generic competition is nearing for hepatitis C medicines formulated with Gilead’s sofosbuvir in Chile, following moves by the health ministry to allow compulsory licensing.
Astellas and Gilead In Spotlight As Compulsory Licensing Pressure Mounts In Chile
Pressure is mounting in Chile for the government to pursue compulsory licensing. Gilead’s Sovadi (sofosbuvir) and Astellas’s prostate cancer drug Xtandi (enzalutamide) could be among the drugs eventually opened up to generic competition.